Pharmacological inhibition of myostatin effectively ameliorates osteolytic lesions in syngeneic and xenograft breast cancer mouse models

Julia Reinhardt, Berno Dankbar, Fabienne Geers, Eugenie Werbenko, Christiane Geyer, Annalen Bleckmann, Kerstin Menck, Anne Grözinger, Wolfgang Hartmann, Joke Tio, Carsten Höltke, Anne Helfen, Andreas Lodberg, Rosa Al-Qasemi, Denise Beckmann, Sarah Bödecker, Simon Kleimann, Linda Wessendorf, Deniz Wawersig, Thomas Pap, Corinna Wehmeyer

Open source

DOI: 10.1038/s41388-025-03622-7
Published: 2025-11-17
Container: Oncogene
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s41388-025-03622-7,
  title = {Pharmacological inhibition of myostatin effectively ameliorates osteolytic lesions in syngeneic and xenograft breast cancer mouse models},
  author = {Julia Reinhardt and Berno Dankbar and Fabienne Geers and Eugenie Werbenko and Christiane Geyer and Annalen Bleckmann and Kerstin Menck and Anne Grözinger and Wolfgang Hartmann and Joke Tio and Carsten Höltke and Anne Helfen and Andreas Lodberg and Rosa Al-Qasemi and Denise Beckmann and Sarah Bödecker and Simon Kleimann and Linda Wessendorf and Deniz Wawersig and Thomas Pap and Corinna Wehmeyer},
  year = {2025},
  journal = {Oncogene},
  doi = {10.1038/s41388-025-03622-7},
  url = {https://doi.org/10.1038/s41388-025-03622-7}
}

RIS

TY  - JOUR
TI  - Pharmacological inhibition of myostatin effectively ameliorates osteolytic lesions in syngeneic and xenograft breast cancer mouse models
AU  - Julia Reinhardt
AU  - Berno Dankbar
AU  - Fabienne Geers
AU  - Eugenie Werbenko
AU  - Christiane Geyer
AU  - Annalen Bleckmann
AU  - Kerstin Menck
AU  - Anne Grözinger
AU  - Wolfgang Hartmann
AU  - Joke Tio
AU  - Carsten Höltke
AU  - Anne Helfen
AU  - Andreas Lodberg
AU  - Rosa Al-Qasemi
AU  - Denise Beckmann
AU  - Sarah Bödecker
AU  - Simon Kleimann
AU  - Linda Wessendorf
AU  - Deniz Wawersig
AU  - Thomas Pap
AU  - Corinna Wehmeyer
PY  - 2025
JO  - Oncogene
DO  - 10.1038/s41388-025-03622-7
UR  - https://doi.org/10.1038/s41388-025-03622-7
ER  -

APA

Reinhardt, J., Dankbar, B., Geers, F., Werbenko, E., Geyer, C., Bleckmann, A., Menck, K., Grözinger, A., Hartmann, W., Tio, J., Höltke, C., Helfen, A., Lodberg, A., Al-Qasemi, R., Beckmann, D., Bödecker, S., Kleimann, S., Wessendorf, L., Wawersig, D., Pap, T., & Wehmeyer, C. (2025). Pharmacological inhibition of myostatin effectively ameliorates osteolytic lesions in syngeneic and xenograft breast cancer mouse models. Oncogene. https://doi.org/10.1038/s41388-025-03622-7

Source records

crossref · retrieved 2026-09-26T04:45:54.368Z